Capella BioScience's Seed VC Round

Capella BioScience raised a round of funding on December 31, 2014.

Capella BioScience uses technologies to develop novel medicines based on monoclonal antibodies (mAbs) to the next generation of important therapeutic targets in oncology and autoimmune disease.…

Articles about Capella BioScience's Seed VC Round: